EGFR and lung cancer: In summary, autophagosome-mediated EGFR down-regulation induced by CX-4945, a potent and selective CK2 inhibitor, enhances the efficacy of EGFR-TKI on EGFR-mutant lung-cancer cells with resistance by T790M.